Te
Tessera Ther
Cambridge MAFounded 2018100 employees
Private CapbiotechPrivateGenetic Medicine
Platform: Gene Writing
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| TES-3466 | TES-3466 | NDA/BLA | 1 | GLP-1R | Alzheimer'sFSGS | ||
| TES-8949 | TES-8949 | Phase 3 | 2 | AuroraA | MigraineObesity |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)